Acknowledging a global decline in demand for its Essure contraceptive device, Bayer announced last week that it was pulling the device off the market around the world – except for the United States. In the same statement, the medical manufacturing giant sought to assure the public that the decision was “not linked to a safety or product quality problem.”
Tens of thousands of women in the ...
continue reading...